Upadacitinib

Short Description:

API’s Name Indication Innovator Patent Expiry Date(The U.S)
Upadacitinib Atopic Dermatitis ABBVIE INC  Dec.01,2030


Product Detail

Product Tags


  • Previous:
  • Next:

  • Write your message here and send it to us